Skip to main content

Table 2 Demographic data collected at the end of the follow-up

From: Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study

Variables Combined therapy group (n=27) Aspirin group (n=26) P
  Mean Std Mean Std  
BMI (kg/m2) 24.35 3.40 23.62 3.32 0.429
SBP (mmHg) 142.00 13.65 152.36 22.00 0.044*
DBP (mmHg) 74.70 7.60 79.93 12.53 0.071
HbA1C (%) 7.27 1.29 7.06 1.05 0.522
FBG (mmol/L) 7.58 2.04 6.90 1.43 0.169
CHOL (mmol/L) 4.55 1.14 4.93 1.03 0.209
TG (mmol/L) 1.60 1.09 1.93 1.44 0.350
HDL-C (mmol/L) 1.16 0.31 1.23 0.34 0.491
LDL-C (mmol/L) 2.90 0.80 3.14 0.79 0.274
AST (U/L) 17.26 4.64 23.65 11.62 0.011*
ALT (U/L) 18.04 7.71 22.69 16.78 0.198
BUN (mmol/L) 6.67 2.23 6.60 2.62 0.921
CREA (μmol/L) 101.85 28.56 99.84 30.87 0.807
CCR (ml/min) 57.35 17.79 55.76 21.69 0.771
Medication use
 Antihypertensive drugs (%) 37.5 / 21.9 / 0.171
 Insulin (%) 21.9 / 9.4 / 0.302
 Statins (%) 9.4 / 3.1 / 0.613
  1. Plus-minus values are mean±S.D. * indicated p<0.05